by Endotracheal tubes are medical devices that are inserted through the mouth or nose and then placed in the trachea (windpipe) to provide an open airway for oxygen delivery and removal of carbon dioxide during mechanical ventilation or anesthesia. Endotracheal intubation plays a vital role in maintaining a patent airway and is an integral part of the management of critically ill and post-surgical patients. The global demand for endotracheal tubes has been rising primarily due to the growing incidence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer and respiratory infections. Furthermore, increasing number of surgical procedures and rising geriatric population susceptible to chronic illnesses is also fueling market growth.
The global Endotracheal Tube Market is estimated to be valued at US$ 920 Mn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends gaining traction in the endotracheal tube market is the emergence of single-use tubes to reduce the risk of infection. Single-use endotracheal tubes are disposable and used only on a single patient to avoid risk of cross-contamination. Several manufacturers are focusing on development of single-use tubes made from biocompatible and non-toxic materials. For instance, Teleflex Inc. offers single-patient-use endotracheal tubes under the brand name Microcuff Endotracheal Tube. Similarly, Medtronic offers single-use tubes such as ULTRA Flex and ULTRA Soft. Owing to stringent regulations regarding hospital-acquired infections, demand for single-use endotracheal tubes is growing significantly. This trend is expected to continue and boost the overall market growth over the forecast period.
Porter’s Analysis
Threat of new entrants: Low barriers to entry like capital requirements and technology; however, the market is dominated by a few major players.
Bargaining power of buyers: High as buyers can negotiate on price and quality due to availability of substitutes.
Bargaining power of suppliers: Low as there are many suppliers and raw material providers in the market.
Threat of new substitutes: Low as endotracheal tubes do not have close substitutes for airway management procedures.
Competitive rivalry: High as the market is dominated by large multinational companies.
Key Takeaways
The Global Endotracheal Tube Market Size is expected to witness high growth. The market size for 2023 is estimated to be US$ 920 Mn registering a CAGR of 9.0% during the forecast period of 2023 to 2030.
Regional analysis – North America region currently dominates the endotracheal tube market owing to technological advancements and increasing ICU admissions. Asia Pacific region is expected to grow at the fastest pace during the forecast period due to rising healthcare spending and large patient pool.
Key players – Key players operating in the Endotracheal Tube market are Medtronic Plc, Teleflex Inc., ConvaTec Inc., Smiths Medical, Neurovision Medical Products, Intersurgical Inc., Royax, Novo Klinik-Service GmbH, Avanos Medical, Inc., Bactiguard, and N8 Medical LLC. Medtronic Plc and Teleflex Inc. are the market leaders in endotracheal tubes.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
